Company / Profit Margin
NEUROONE MEDICAL TECHNOLOGIES Corp Profit Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-356.7%
FY2025
5-year range
-7656.7% / -356.7%
FY2021-FY2025
Trend
+41.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has fluctuated over the past 9 years, ranging from -7656.7% in FY2021 to -356.7% in FY2025.
Based on SEC 10-K filings.
-356.7% in FY2025 with a 10-year CAGR of +4332.0%.
Improved from -5841.9% to -356.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +5227.5pp
- 5-Year Change
- -
- 10-Year Change
- +4332.0pp
Key checks
Key Insights
- In FY2025, profit margin increased 41.3% year-over-year.
- Lowest profit margin in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -356.7% | +41.3% |
| FY2024 | -607.4% | +89.6% |
| FY2023 | -5841.9% | -4.6% |
| FY2022 | -5584.3% | +27.1% |
| FY2021 | -7656.7% | - |
| FY2016 | - | - |
| FY2015 | -4688.8% | -91.7% |
| FY2014 | -2446.3% | -378.4% |
| FY2012 | -511.4% | +1.3% |
| FY2011 | -517.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026